Stifel Financial Corp Champions Oncology, Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.5 - $5.23 $1,125 - $1,307	-250 Reduced 2.23%	10,942 $56,000
Q1 2024 May 13, 2024	BUY	$4.9 - $6.91 $54,840 - $77,336	11,192 New	11,192 $54,000
Q3 2023 Nov 13, 2023	SELL	$5.2 - $7.32 $39,707 - $55,895	-7,636 Reduced 42.24%	10,442 $64,000
Q2 2023 Aug 14, 2023	SELL	$4.11 - $6.81 $17,455 - $28,922	-4,247 Reduced 19.02%	18,078 $115,000
Q1 2023 May 12, 2023	BUY	$4.0 - $4.67 $89,300 - $104,257	22,325 New	22,325 $89,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $102M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.